OraSure Seeks Regulatory Feedback For Marketing Home-Use HIV Test
This article was originally published in The Tan Sheet
Executive Summary
OraSure Technologies will seek guidance from FDA's Blood Product's Advisory Committee on making its OraQuick Advance oral fluid HIV test available over the counter for use in the home
You may also be interested in...
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30
Chembio HIV Tests Could Present OTC Competition For OraSure
Chembio Diagnostics intends to pursue OTC status for its SURE CHECK HIV 1/2 and HIV 1/2 STAT-PAK rapid tests, the company said upon announcing FDA approval of the two products May 30